{"disease":{"id":"prostate-cancer-patients","name":"prostate cancer patients"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07484971","title":"Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Société Algérienne de Formation et Recherche en Oncologie","has_results":false},{"nct_id":"NCT07343349","title":"Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions","phase":"NA","overall_status":"RECRUITING","enrollment_count":1016,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT07308990","title":"Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"N.N. Alexandrov National Cancer Centre","has_results":false},{"nct_id":"NCT07158138","title":"A Digitally Distributed Yoga Intervention in Prostate Cancer Rehabilitation : Protocol for a Randomized Controlled Trial","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Region Örebro County","has_results":false},{"nct_id":"NCT06970847","title":"64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Clarity Pharmaceuticals Ltd","has_results":false},{"nct_id":"NCT07253987","title":"Cancer Survivors Program","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Masaryk Memorial Cancer Institute","has_results":false},{"nct_id":"NCT02155998","title":"Non-Interventional Study PREVENT","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07126860","title":"The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Ludwig-Maximilians - University of Munich","has_results":false},{"nct_id":"NCT06343077","title":"Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":114,"lead_sponsor_name":"Ashutosh Kumar Tewari","has_results":false},{"nct_id":"NCT06636682","title":"FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Cellvax Therapeutics Inc","has_results":false},{"nct_id":"NCT03795207","title":"Prostate Cancer With OligometaSTatic Relapse: Combining Stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":96,"lead_sponsor_name":"Institut Cancerologie de l'Ouest","has_results":false},{"nct_id":"NCT07514065","title":"TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":78,"lead_sponsor_name":"Tasly Pharmaceutical Group Co., Ltd","has_results":false},{"nct_id":"NCT07489729","title":"Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Tanta University","has_results":false},{"nct_id":"NCT07156903","title":"Evaluation of Needs of Patients and Care-givers During and After Radiotherapy of Patients With Prostate Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT07325721","title":"Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":46,"lead_sponsor_name":"Medical University of South Carolina","has_results":false},{"nct_id":"NCT07243795","title":"Ejaculatory Behavior and Seminal Vesicle Size During Radical Prostatectomy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT07135102","title":"A Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of [225Ac]Ac-PSMA-XT Injection in Patients With Metastatic Castration-resistant Prostate Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Xiaorong Sun","has_results":false},{"nct_id":"NCT07130682","title":"Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":35,"lead_sponsor_name":"Hong Kong Sanatorium & Hospital","has_results":false},{"nct_id":"NCT07101354","title":"Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Haitao Niu, MD","has_results":false},{"nct_id":"NCT06972628","title":"Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Ebrahim S Delpassand","has_results":false},{"nct_id":"NCT06653751","title":"Reminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false},{"nct_id":"NCT06784115","title":"A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":27,"lead_sponsor_name":"University Hospital Schleswig-Holstein","has_results":false},{"nct_id":"NCT07387510","title":"PSMA-Targeted Intraoperative Fluorescent Imaging Agents (DGPR1008): Validation Across Different Time Windows","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":27,"lead_sponsor_name":"Haitao Niu, MD","has_results":false},{"nct_id":"NCT07024030","title":"Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging of Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Haitao Niu, MD","has_results":false},{"nct_id":"NCT04676035","title":"The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT03643107","title":"Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Allarity Therapeutics","has_results":false},{"nct_id":"NCT06872489","title":"Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Second Life Therapeutics","has_results":false}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}